Disease Comorbidity
Disease Comorbidity - Related Videos
09:45
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
0 Views •
Cited by 8 •
2016
To investigate the co-morbid Alzheimer's disease (AD) and stroke condition in a novel model, three behavior tasks are described that assess both motor control and cognitive behaviors. These tasks include the beam-walk task, cylinder task and Morris water maze.
10:47
An Overview of Genetics and Disease
0 Views •
2023
Many human diseases are associated with mutations or variations in genetic sequences. Some of these genetic variants are heritable, passed down from generation to generation, while others arise sporadically during an organism’s life and cause diseases such as cancer. Researchers are trying to identify and characterize these genetic alterations in the hopes of improving diagnosis and therapeutic options for patients.In this video, we will examine the history of genetic disease research, and...
05:32
Comparing Eye-tracking Data of Children with High-functioning ASD, Comorbid ADHD, and of a Control Watching Social Videos
0 Views •
Cited by 9 •
2018
This is a qualitative comparative case study analysis of eye-tracking data on the first moments of social video scenes as viewed by three participants: one with autism spectrum disorder, one with comorbid attention deficit-hyperactive disorder, and one neurotypical control.
01:30
Inflammatory Bowel Disease II: Crohn's Disease
0 Views •
2025
Introduction Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment. Crohn's disease Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
0 Views •
Cited by 25 •
2014
The degree of vascular dysfunction and contributing physiological mechanisms can be assessed in patients with chronic kidney disease by measuring brachial artery flow-mediated dilation, aortic pulse-wave velocity, and vascular endothelial cell protein expression.
FAQs
Researchers compare whether the same genetic or environmental exposure is associated with both conditions, then examine whether the relationship plausibly reflects one disorder causing or influencing the other. This distinction prevents disease associations from being treated as proven causes and improves interpretation of prognosis, diagnosis, and treatment patterns.
Chronic inflammation can serve as a shared biological pathway connecting otherwise different disorders. When that pathway affects multiple organ systems, the presence or severity of one condition may help explain changes in another. Recognizing this connection gives biologists a mechanistic basis for studying disease interactions rather than viewing each disorder in isolation.
One disease can alter the expected course of another, while a therapy directed at one condition may affect the other condition as well. These interactions can change prognosis and complicate treatment decisions. Accounting for them helps investigators and clinicians interpret outcomes in patients whose disorders cannot be evaluated independently.
A study can first map the conditions that occur together, then consider shared genetic or environmental risks, common biological pathways, and effects of one disease or its treatment on the other. Researchers must next interpret these links cautiously, separating observed associations from causal explanations before applying findings to prognosis or therapy.
Patterns of co-occurring conditions can help identify people who are more vulnerable to different disease outcomes or complex interactions. Risk prediction uses those patterns to refine expectations about prognosis, while individualized therapeutic strategies account for the patient’s combined disease burden. The goal is not merely to count conditions, but to use their relationships.
Models that reflect real-world disease complexity can represent interactions that would be missed when disorders are studied separately. They help biologists investigate links among organ systems, examine how shared mechanisms may shape multiple conditions, and interpret findings in a context closer to patients whose prognosis and treatment are affected by comorbidity.